| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $371.8M | +7.3% |
| Cost of Revenue | $58.6M | +11.8% |
| Gross Profit | $313.2M | +6.5% |
| R&D Expense | $63.5M | +17.7% |
| SG&A Expense | $71.1M | -11.7% |
| Operating Income | $47.4M | +42.2% |
| Pre-tax Income | $30.4M | +162.5% |
| Income Tax | $13.7M | +19.5% |
| Net Income | $16.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.8M | +48.1% |
| Accounts Receivable | $34.8M | +5.3% |
| Current Assets | $154.2M | +27.4% |
| Total Assets | $1.08B | +2.2% |
| Current Liabilities | $61.8M | +1.5% |
| Long-term Debt | $337.0M | -0.6% |
| Total Liabilities | $436.8M | -0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $71.4M | +57.5% |
| Capital Expenditures | $12.8M | -58.1% |
| Investing Cash Flow | -$30.2M | +13.3% |
| Financing Cash Flow | -$10.4M | +75.4% |
| Free Cash Flow | $58.6M | +299.1% |
| — |
| EPS (Basic) | $0.09 | — |
| EPS (Diluted) | $0.09 | — |
| Stockholders' Equity |
| $642.1M |
| +3.8% |